The global Depression Treatment Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Depression Treatment Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Depression Treatment Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Depression Treatment Therapy in Seasonal affective disorder (SAD) is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Depression Treatment Therapy include Pfizer, Teva Pharmaceutical, Johnson and Johnson, Merck, Eli Lily, Novartis, Sanofi, AstraZeneca and Allergan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Depression Treatment Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Depression Treatment Therapy.

Report Scope

The Depression Treatment Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Depression Treatment Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Depression Treatment Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Depression Treatment Therapy Market Report

Report Metric	Details
Report Name	Depression Treatment Therapy Market
Segment by Type	Drugs Treatment device
Segment by Application	Seasonal affective disorder (SAD) Major depression Dysthymia disorder Postpartum depression Atypical depression Psychotic depression Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Teva Pharmaceutical, Johnson and Johnson, Merck, Eli Lily, Novartis, Sanofi, AstraZeneca, Allergan, Mayo Clinic, Bristol-Myers Squibb, Takeda, Brainsway, Lundbeck, NeuroStar, Otsuka, VistaGen Therapeutics, Silver Oak Health, NeuroSigma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Depression Treatment Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Depression Treatment Therapy Market report?

Ans: The main players in the Depression Treatment Therapy Market are Pfizer, Teva Pharmaceutical, Johnson and Johnson, Merck, Eli Lily, Novartis, Sanofi, AstraZeneca, Allergan, Mayo Clinic, Bristol-Myers Squibb, Takeda, Brainsway, Lundbeck, NeuroStar, Otsuka, VistaGen Therapeutics, Silver Oak Health, NeuroSigma

What are the Application segmentation covered in the Depression Treatment Therapy Market report?

Ans: The Applications covered in the Depression Treatment Therapy Market report are Seasonal affective disorder (SAD), Major depression, Dysthymia disorder, Postpartum depression, Atypical depression, Psychotic depression, Other

What are the Type segmentation covered in the Depression Treatment Therapy Market report?

Ans: The Types covered in the Depression Treatment Therapy Market report are Drugs, Treatment device

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Depression Treatment Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Drugs

1.2.3 Treatment device

1.3 Market by Application

1.3.1 Global Depression Treatment Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Seasonal affective disorder (SAD)

1.3.3 Major depression

1.3.4 Dysthymia disorder

1.3.5 Postpartum depression

1.3.6 Atypical depression

1.3.7 Psychotic depression

1.3.8 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Depression Treatment Therapy Market Perspective (2019-2030)

2.2 Depression Treatment Therapy Growth Trends by Region

2.2.1 Global Depression Treatment Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Depression Treatment Therapy Historic Market Size by Region (2019-2024)

2.2.3 Depression Treatment Therapy Forecasted Market Size by Region (2025-2030)

2.3 Depression Treatment Therapy Market Dynamics

2.3.1 Depression Treatment Therapy Industry Trends

2.3.2 Depression Treatment Therapy Market Drivers

2.3.3 Depression Treatment Therapy Market Challenges

2.3.4 Depression Treatment Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Depression Treatment Therapy Players by Revenue

3.1.1 Global Top Depression Treatment Therapy Players by Revenue (2019-2024)

3.1.2 Global Depression Treatment Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Depression Treatment Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Depression Treatment Therapy Revenue

3.4 Global Depression Treatment Therapy Market Concentration Ratio

3.4.1 Global Depression Treatment Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Depression Treatment Therapy Revenue in 2023

3.5 Depression Treatment Therapy Key Players Head office and Area Served

3.6 Key Players Depression Treatment Therapy Product Solution and Service

3.7 Date of Enter into Depression Treatment Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Depression Treatment Therapy Breakdown Data by Type

4.1 Global Depression Treatment Therapy Historic Market Size by Type (2019-2024)

4.2 Global Depression Treatment Therapy Forecasted Market Size by Type (2025-2030)

5 Depression Treatment Therapy Breakdown Data by Application

5.1 Global Depression Treatment Therapy Historic Market Size by Application (2019-2024)

5.2 Global Depression Treatment Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Depression Treatment Therapy Market Size (2019-2030)

6.2 North America Depression Treatment Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Depression Treatment Therapy Market Size by Country (2019-2024)

6.4 North America Depression Treatment Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Depression Treatment Therapy Market Size (2019-2030)

7.2 Europe Depression Treatment Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Depression Treatment Therapy Market Size by Country (2019-2024)

7.4 Europe Depression Treatment Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Depression Treatment Therapy Market Size (2019-2030)

8.2 Asia-Pacific Depression Treatment Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Depression Treatment Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Depression Treatment Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Depression Treatment Therapy Market Size (2019-2030)

9.2 Latin America Depression Treatment Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Depression Treatment Therapy Market Size by Country (2019-2024)

9.4 Latin America Depression Treatment Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Depression Treatment Therapy Market Size (2019-2030)

10.2 Middle East & Africa Depression Treatment Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Depression Treatment Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Depression Treatment Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Depression Treatment Therapy Introduction

11.1.4 Pfizer Revenue in Depression Treatment Therapy Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 Teva Pharmaceutical

11.2.1 Teva Pharmaceutical Company Detail

11.2.2 Teva Pharmaceutical Business Overview

11.2.3 Teva Pharmaceutical Depression Treatment Therapy Introduction

11.2.4 Teva Pharmaceutical Revenue in Depression Treatment Therapy Business (2019-2024)

11.2.5 Teva Pharmaceutical Recent Development

11.3 Johnson and Johnson

11.3.1 Johnson and Johnson Company Detail

11.3.2 Johnson and Johnson Business Overview

11.3.3 Johnson and Johnson Depression Treatment Therapy Introduction

11.3.4 Johnson and Johnson Revenue in Depression Treatment Therapy Business (2019-2024)

11.3.5 Johnson and Johnson Recent Development

11.4 Merck

11.4.1 Merck Company Detail

11.4.2 Merck Business Overview

11.4.3 Merck Depression Treatment Therapy Introduction

11.4.4 Merck Revenue in Depression Treatment Therapy Business (2019-2024)

11.4.5 Merck Recent Development

11.5 Eli Lily

11.5.1 Eli Lily Company Detail

11.5.2 Eli Lily Business Overview

11.5.3 Eli Lily Depression Treatment Therapy Introduction

11.5.4 Eli Lily Revenue in Depression Treatment Therapy Business (2019-2024)

11.5.5 Eli Lily Recent Development

11.6 Novartis

11.6.1 Novartis Company Detail

11.6.2 Novartis Business Overview

11.6.3 Novartis Depression Treatment Therapy Introduction

11.6.4 Novartis Revenue in Depression Treatment Therapy Business (2019-2024)

11.6.5 Novartis Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Detail

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Depression Treatment Therapy Introduction

11.7.4 Sanofi Revenue in Depression Treatment Therapy Business (2019-2024)

11.7.5 Sanofi Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Detail

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Depression Treatment Therapy Introduction

11.8.4 AstraZeneca Revenue in Depression Treatment Therapy Business (2019-2024)

11.8.5 AstraZeneca Recent Development

11.9 Allergan

11.9.1 Allergan Company Detail

11.9.2 Allergan Business Overview

11.9.3 Allergan Depression Treatment Therapy Introduction

11.9.4 Allergan Revenue in Depression Treatment Therapy Business (2019-2024)

11.9.5 Allergan Recent Development

11.10 Mayo Clinic

11.10.1 Mayo Clinic Company Detail

11.10.2 Mayo Clinic Business Overview

11.10.3 Mayo Clinic Depression Treatment Therapy Introduction

11.10.4 Mayo Clinic Revenue in Depression Treatment Therapy Business (2019-2024)

11.10.5 Mayo Clinic Recent Development

11.11 Bristol-Myers Squibb

11.11.1 Bristol-Myers Squibb Company Detail

11.11.2 Bristol-Myers Squibb Business Overview

11.11.3 Bristol-Myers Squibb Depression Treatment Therapy Introduction

11.11.4 Bristol-Myers Squibb Revenue in Depression Treatment Therapy Business (2019-2024)

11.11.5 Bristol-Myers Squibb Recent Development

11.12 Takeda

11.12.1 Takeda Company Detail

11.12.2 Takeda Business Overview

11.12.3 Takeda Depression Treatment Therapy Introduction

11.12.4 Takeda Revenue in Depression Treatment Therapy Business (2019-2024)

11.12.5 Takeda Recent Development

11.13 Brainsway

11.13.1 Brainsway Company Detail

11.13.2 Brainsway Business Overview

11.13.3 Brainsway Depression Treatment Therapy Introduction

11.13.4 Brainsway Revenue in Depression Treatment Therapy Business (2019-2024)

11.13.5 Brainsway Recent Development

11.14 Lundbeck

11.14.1 Lundbeck Company Detail

11.14.2 Lundbeck Business Overview

11.14.3 Lundbeck Depression Treatment Therapy Introduction

11.14.4 Lundbeck Revenue in Depression Treatment Therapy Business (2019-2024)

11.14.5 Lundbeck Recent Development

11.15 NeuroStar

11.15.1 NeuroStar Company Detail

11.15.2 NeuroStar Business Overview

11.15.3 NeuroStar Depression Treatment Therapy Introduction

11.15.4 NeuroStar Revenue in Depression Treatment Therapy Business (2019-2024)

11.15.5 NeuroStar Recent Development

11.16 Otsuka

11.16.1 Otsuka Company Detail

11.16.2 Otsuka Business Overview

11.16.3 Otsuka Depression Treatment Therapy Introduction

11.16.4 Otsuka Revenue in Depression Treatment Therapy Business (2019-2024)

11.16.5 Otsuka Recent Development

11.17 VistaGen Therapeutics

11.17.1 VistaGen Therapeutics Company Detail

11.17.2 VistaGen Therapeutics Business Overview

11.17.3 VistaGen Therapeutics Depression Treatment Therapy Introduction

11.17.4 VistaGen Therapeutics Revenue in Depression Treatment Therapy Business (2019-2024)

11.17.5 VistaGen Therapeutics Recent Development

11.18 Silver Oak Health

11.18.1 Silver Oak Health Company Detail

11.18.2 Silver Oak Health Business Overview

11.18.3 Silver Oak Health Depression Treatment Therapy Introduction

11.18.4 Silver Oak Health Revenue in Depression Treatment Therapy Business (2019-2024)

11.18.5 Silver Oak Health Recent Development

11.19 NeuroSigma

11.19.1 NeuroSigma Company Detail

11.19.2 NeuroSigma Business Overview

11.19.3 NeuroSigma Depression Treatment Therapy Introduction

11.19.4 NeuroSigma Revenue in Depression Treatment Therapy Business (2019-2024)

11.19.5 NeuroSigma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

VistaGen Therapeutics

Silver Oak Health

NeuroSigma

List of Tables

Table 1. Global Depression Treatment Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Drugs

Table 3. Key Players of Treatment device

Table 4. Global Depression Treatment Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Depression Treatment Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Depression Treatment Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Depression Treatment Therapy Market Share by Region (2019-2024)

Table 8. Global Depression Treatment Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Depression Treatment Therapy Market Share by Region (2025-2030)

Table 10. Depression Treatment Therapy Market Trends

Table 11. Depression Treatment Therapy Market Drivers

Table 12. Depression Treatment Therapy Market Challenges

Table 13. Depression Treatment Therapy Market Restraints

Table 14. Global Depression Treatment Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Depression Treatment Therapy Market Share by Players (2019-2024)

Table 16. Global Top Depression Treatment Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depression Treatment Therapy as of 2023)

Table 17. Ranking of Global Top Depression Treatment Therapy Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Depression Treatment Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Depression Treatment Therapy Product Solution and Service

Table 21. Date of Enter into Depression Treatment Therapy Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Depression Treatment Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Depression Treatment Therapy Revenue Market Share by Type (2019-2024)

Table 25. Global Depression Treatment Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Depression Treatment Therapy Revenue Market Share by Type (2025-2030)

Table 27. Global Depression Treatment Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Depression Treatment Therapy Revenue Market Share by Application (2019-2024)

Table 29. Global Depression Treatment Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Depression Treatment Therapy Revenue Market Share by Application (2025-2030)

Table 31. North America Depression Treatment Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Depression Treatment Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Depression Treatment Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Depression Treatment Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Depression Treatment Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Depression Treatment Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Depression Treatment Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Depression Treatment Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Depression Treatment Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Depression Treatment Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Depression Treatment Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Depression Treatment Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Depression Treatment Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Depression Treatment Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Depression Treatment Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 46. Pfizer Company Detail

Table 47. Pfizer Business Overview

Table 48. Pfizer Depression Treatment Therapy Product

Table 49. Pfizer Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 50. Pfizer Recent Development

Table 51. Teva Pharmaceutical Company Detail

Table 52. Teva Pharmaceutical Business Overview

Table 53. Teva Pharmaceutical Depression Treatment Therapy Product

Table 54. Teva Pharmaceutical Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 55. Teva Pharmaceutical Recent Development

Table 56. Johnson and Johnson Company Detail

Table 57. Johnson and Johnson Business Overview

Table 58. Johnson and Johnson Depression Treatment Therapy Product

Table 59. Johnson and Johnson Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 60. Johnson and Johnson Recent Development

Table 61. Merck Company Detail

Table 62. Merck Business Overview

Table 63. Merck Depression Treatment Therapy Product

Table 64. Merck Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 65. Merck Recent Development

Table 66. Eli Lily Company Detail

Table 67. Eli Lily Business Overview

Table 68. Eli Lily Depression Treatment Therapy Product

Table 69. Eli Lily Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 70. Eli Lily Recent Development

Table 71. Novartis Company Detail

Table 72. Novartis Business Overview

Table 73. Novartis Depression Treatment Therapy Product

Table 74. Novartis Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 75. Novartis Recent Development

Table 76. Sanofi Company Detail

Table 77. Sanofi Business Overview

Table 78. Sanofi Depression Treatment Therapy Product

Table 79. Sanofi Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 80. Sanofi Recent Development

Table 81. AstraZeneca Company Detail

Table 82. AstraZeneca Business Overview

Table 83. AstraZeneca Depression Treatment Therapy Product

Table 84. AstraZeneca Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 85. AstraZeneca Recent Development

Table 86. Allergan Company Detail

Table 87. Allergan Business Overview

Table 88. Allergan Depression Treatment Therapy Product

Table 89. Allergan Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 90. Allergan Recent Development

Table 91. Mayo Clinic Company Detail

Table 92. Mayo Clinic Business Overview

Table 93. Mayo Clinic Depression Treatment Therapy Product

Table 94. Mayo Clinic Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 95. Mayo Clinic Recent Development

Table 96. Bristol-Myers Squibb Company Detail

Table 97. Bristol-Myers Squibb Business Overview

Table 98. Bristol-Myers Squibb Depression Treatment Therapy Product

Table 99. Bristol-Myers Squibb Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 100. Bristol-Myers Squibb Recent Development

Table 101. Takeda Company Detail

Table 102. Takeda Business Overview

Table 103. Takeda Depression Treatment Therapy Product

Table 104. Takeda Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 105. Takeda Recent Development

Table 106. Brainsway Company Detail

Table 107. Brainsway Business Overview

Table 108. Brainsway Depression Treatment Therapy Product

Table 109. Brainsway Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 110. Brainsway Recent Development

Table 111. Lundbeck Company Detail

Table 112. Lundbeck Business Overview

Table 113. Lundbeck Depression Treatment Therapy Product

Table 114. Lundbeck Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 115. Lundbeck Recent Development

Table 116. NeuroStar Company Detail

Table 117. NeuroStar Business Overview

Table 118. NeuroStar Depression Treatment Therapy Product

Table 119. NeuroStar Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 120. NeuroStar Recent Development

Table 121. Otsuka Company Detail

Table 122. Otsuka Business Overview

Table 123. Otsuka Depression Treatment Therapy Product

Table 124. Otsuka Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 125. Otsuka Recent Development

Table 126. VistaGen Therapeutics Company Detail

Table 127. VistaGen Therapeutics Business Overview

Table 128. VistaGen Therapeutics Depression Treatment Therapy Product

Table 129. VistaGen Therapeutics Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 130. VistaGen Therapeutics Recent Development

Table 131. Silver Oak Health Company Detail

Table 132. Silver Oak Health Business Overview

Table 133. Silver Oak Health Depression Treatment Therapy Product

Table 134. Silver Oak Health Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 135. Silver Oak Health Recent Development

Table 136. NeuroSigma Company Detail

Table 137. NeuroSigma Business Overview

Table 138. NeuroSigma Depression Treatment Therapy Product

Table 139. NeuroSigma Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million)

Table 140. NeuroSigma Recent Development

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Depression Treatment Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Depression Treatment Therapy Market Share by Type: 2023 VS 2030

Figure 3. Drugs Features

Figure 4. Treatment device Features

Figure 5. Global Depression Treatment Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Depression Treatment Therapy Market Share by Application: 2023 VS 2030

Figure 7. Seasonal affective disorder (SAD) Case Studies

Figure 8. Major depression Case Studies

Figure 9. Dysthymia disorder Case Studies

Figure 10. Postpartum depression Case Studies

Figure 11. Atypical depression Case Studies

Figure 12. Psychotic depression Case Studies

Figure 13. Other Case Studies

Figure 14. Depression Treatment Therapy Report Years Considered

Figure 15. Global Depression Treatment Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Depression Treatment Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Depression Treatment Therapy Market Share by Region: 2023 VS 2030

Figure 18. Global Depression Treatment Therapy Market Share by Players in 2023

Figure 19. Global Top Depression Treatment Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depression Treatment Therapy as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Depression Treatment Therapy Revenue in 2023

Figure 21. North America Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Depression Treatment Therapy Market Share by Country (2019-2030)

Figure 23. United States Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Depression Treatment Therapy Market Share by Country (2019-2030)

Figure 27. Germany Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Depression Treatment Therapy Market Share by Region (2019-2030)

Figure 35. China Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Depression Treatment Therapy Market Share by Country (2019-2030)

Figure 43. Mexico Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Depression Treatment Therapy Market Share by Country (2019-2030)

Figure 47. Turkey Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Pfizer Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 50. Teva Pharmaceutical Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 51. Johnson and Johnson Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 52. Merck Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 53. Eli Lily Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 54. Novartis Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 55. Sanofi Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 56. AstraZeneca Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 57. Allergan Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 58. Mayo Clinic Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 60. Takeda Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 61. Brainsway Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 62. Lundbeck Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 63. NeuroStar Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 64. Otsuka Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 65. VistaGen Therapeutics Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 66. Silver Oak Health Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 67. NeuroSigma Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions